|

Hyperthermic Intraperitoneal Chemotherapy Clinical Trials

2 actively recruiting trials across 1 location

▼ -1 trial since August 2026

Also known as: HIPEC

Pipeline

Phase 2: 2

Top Sponsors

  • Mayo Clinic2

Indications

  • Metastatic Malignant Neoplasm in the Peritoneum2
  • Cancer2
  • Metastatic Pancreatic Carcinoma1
  • Gastroesophageal Junction Adenocarcinoma1
  • Gastric Adenocarcinoma1

Rochester, Minnesota2 trials

Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis

Mayo Clinic in Rochester

Phase 2
Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

Mayo Clinic in Rochester

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.